About
About Avecho
Board & Leadership
TPM
®
Technology
Portfolio
Pipeline
Phase III Trial
Cannabinoids
Pharmaceutical
Animal Health
Manufacturing
Invest
Investor Centre
Media Centre
Contact
Hit enter to search or ESC to close
Appendix 3X Notices – Three New Directors
April 22, 2015
Click here to read more
Post navigation
Previous Post
Phosphagenics Initiates Oxycodone Patch Dosing in Phase 2 Clinical Trial
Next Post
Notice of 2015 Annual General Meeting
Related Posts
Phosphagenics Expands License Agreement for Diclofenac Gel
May 18, 2016
Phosphagenics Full Year Financial Results
February 28, 2017
TGA pre-submission meeting for insomnia related CBD soft-gel product
May 26, 2021
May 26, 2021